FDA approves COVID-19 vaccine for everyone 16+

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization…

Read More

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

August 18, 2021: The Panel updated the following section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Highlights from the section are summarized below: Human Papillomavirus Disease:New recommendation for cervical cancer screening to start at age 21 based on the HIV/AIDS Cancer Match Study with no…

Read More

COVID-19 Vaccines for Moderately to Severely Immunocompromised People

HIV News Alert

CDC now recommends that people whose immune systems are compromised moderately to severely should receive an additional dose of mRNA COVID-19 vaccine after the initial 2 doses. Widespread vaccination is a critical tool to help stop the pandemic. Read CDC’s statement. What You Need to Know People who are moderately to severely immunocompromised are especially vulnerable to COVID-19…

Read More